Literature DB >> 12242524

Hyperplastic epithelial foci in honeycomb lesions in idiopathic pulmonary fibrosis.

Lei Qunn1, Tamiko Takemura, Soichiro Ikushima, Tsunehiro Ando, Takashi Yanagawa, Osamu Akiyama, Masaru Oritsu, Noboru Tanaka, Toshio Kuroki.   

Abstract

Seventy-two cases of idiopathic pulmonary fibrosis (IPF) were examined from 2856 consecutive autopsy cases at the Japanese Red Cross Medical Center in Tokyo from 1973-1996. Primary lung cancer had arisen in 31 of 72 cases of IPF (43%), significantly higher than the incidence in cases without IPF (8.1%) and in the cases with non-IPF chronic lung diseases (11.9%). Hyperplastic epithelial foci in the honeycomb lesions of IPF cases were significantly more prominent in the lower than in the upper lobe, in cases with or without lung cancer, and they were more prominent in the lower lobe of IPF with than in those without cancer. The length of hyperplastic epithelial foci in the lower lobe of IPF cases was longer than that in interstitial pneumonia-associated with collagen vascular diseases. There was a higher PCNA labeling index of hyperplastic epithelial foci in IPF cases than in cases of interstitial pneumonia-associated with collagen vascular diseases. The PCNA labeling index was almost the same between smokers and nonsmokers with IPF. Overexpression of p53 was observed in hyperplastic epithelial foci in honeycomb lesion of IPF. DNA ploidy analysis of hyperplastic epithelial foci in the paraffin sections of 12 IPF cases revealed aneuploidy patterns in eight cases. These results strongly suggest that accelerated cell proliferation occurs in the honeycomb lesion of IPF, and that regenerative epithelia becomes susceptible to carcinogenic agents in addition to the smoking effect.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12242524     DOI: 10.1007/s00428-002-0618-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  11 in total

Review 1.  Idiopathic pulmonary fibrosis-an epidemiological and pathological review.

Authors:  Andrea T Borchers; Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

2.  Type 2 alveolar cells are stem cells in adult lung.

Authors:  Christina E Barkauskas; Michael J Cronce; Craig R Rackley; Emily J Bowie; Douglas R Keene; Barry R Stripp; Scott H Randell; Paul W Noble; Brigid L M Hogan
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

3.  The self-fulfilling prophecy of pulmonary fibrosis: a selective inspection of pathological signalling loops.

Authors:  Ashley R Rackow; David J Nagel; Claire McCarthy; Jennifer Judge; Shannon Lacy; Margaret A T Freeberg; Thomas H Thatcher; R Matthew Kottmann; Patricia J Sime
Journal:  Eur Respir J       Date:  2020-11-26       Impact factor: 16.671

Review 4.  Epithelial-mesenchymal interactions in pulmonary fibrosis.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Semin Respir Crit Care Med       Date:  2006-12       Impact factor: 3.119

5.  Outcomes of Older Patients with Pulmonary Fibrosis and Non-Small Cell Lung Cancer.

Authors:  Stacey-Ann Whittaker Brown; Maria Padilla; Grace Mhango; Emanuela Taioli; Charles Powell; Juan Wisnivesky
Journal:  Ann Am Thorac Soc       Date:  2019-08

Review 6.  Pulmonary fibrosis: pathogenesis, etiology and regulation.

Authors:  M S Wilson; T A Wynn
Journal:  Mucosal Immunol       Date:  2009-01-07       Impact factor: 7.313

7.  Lung cancer development in patients with connective tissue disease-related interstitial lung disease: A retrospective observational study.

Authors:  Yasunori Enomoto; Naoki Inui; Katsuhiro Yoshimura; Koji Nishimoto; Kazutaka Mori; Masato Kono; Tomoyuki Fujisawa; Noriyuki Enomoto; Yutaro Nakamura; Toshihide Iwashita; Takafumi Suda
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

8.  Lung cancer in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

Authors:  AliReza JafariNezhad; Mohammad Hossein YektaKooshali
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

9.  Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease.

Authors:  Ruoqi Peng; Sriram Sridhar; Gaurav Tyagi; Jonathan E Phillips; Rosario Garrido; Paul Harris; Lisa Burns; Lorena Renteria; John Woods; Leena Chen; John Allard; Palanikumar Ravindran; Hans Bitter; Zhenmin Liang; Cory M Hogaboam; Chris Kitson; David C Budd; Jay S Fine; Carla M T Bauer; Christopher S Stevenson
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

10.  Deficient repair response of IPF fibroblasts in a co-culture model of epithelial injury and repair.

Authors:  Sony Prasad; Cory M Hogaboam; Gabor Jarai
Journal:  Fibrogenesis Tissue Repair       Date:  2014-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.